News

Zepbound Patients Fear Losing Coverage After CVS Deal for Wegovy
Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
The New York Times9d
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients. By Rebecca Robbins ...
BioSpace7d
Lilly’s Zepbound Secures “Superior Benefit-Risk Ratio” Over Novo’s Wegovy
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
U.S. News & World Report7d
Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study
However, CVS Health recently announced that Wegovy will be the preferred option on its list of covered drugs starting July 1, while Zepbound won't be. “We’re going to need to use them all just ...
MedPage Today on MSN6d
CVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers' Bankruptcy
People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...